ARCHIVES

Owens Becomes President, NCCR

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978

Corrections Made To NCI Phone Directory

May 17, 1991

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

Translplants Not Best Choice in Subset of ALL Patients

April 27, 2012